Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826572) titled 'Beyond the Mehran Risk Score: Predictive Value of Total Ischemic Time for Contrast-Induced Nephropathy in ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention' on Sept. 12.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
ST Elevation (STEMI) Myocardial Infarction
Contrast Induced Nephropathy (CIN)
Acute Kidney Injury
Intervention:
Diagnostic Test: Total Ischemic Time Evaluation
Recruitment Status: Not recruiting
Date of First Enrollment: October 1, 2026
Target Sample Size: 400
To know more, visit https://clinicaltrials.gov/study/...